Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
Status
Conditions
Treatments
Details and patient eligibility
About
This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to determine if using platelet rich plasma drops can improve clinically significant dry eye in patients and determine if there is a difference with using two different uses of the plasma tear drops: platelet rich plasma tears and plasma tears without platelets.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Subjects must be diagnosed with clinically significant dry eye.
- Subjects have no active ocular disease or allergic conjunctivitis.
- Subjects must not be using any topical ocular medications within two weeks prior to enrollment.
- Subjects must be willing and able to follow instructions.
- Subjects must have voluntarily agreed to participate in the study by signing the statement of informed consent.
- Subjects must meet plasma donor criteria as established by University of Rochester Transfusion Medicine & Blood Bank.
Exclusion criteria
- Is pregnant at the time of enrolment in the study determined by urine pregnancy test.
- Is currently on a course of antibiotics
- Is considered by the Investigator to not be a suitable candidate for participation and are not at risk for glaucoma.
- Is considered by the University of Rochester Transfusion Medicine & Blood Bank not a suitable candidate for blood donation.
Trial design
Primary purpose
Allocation
Interventional model
Masking
15 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
James Aquavella, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal